Page last updated: 2024-10-22

amsacrine and Bone Marrow Diseases

amsacrine has been researched along with Bone Marrow Diseases in 2 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Case, DC1
Fyfe, D1
Price, C1
Langley, RE1
Pagonis, C1
Houghton, J1
Osborne, L1
Woll, PJ1
Gardner, C1
Baguley, BC1
Carmichael, J1

Trials

1 trial available for amsacrine and Bone Marrow Diseases

ArticleYear
A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:4

    Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Area Under Curve; Bone Marrow Diseases; Dose-Response

2001

Other Studies

1 other study available for amsacrine and Bone Marrow Diseases

ArticleYear
m-AMSA: phase II trial in advanced lymphoma and leukemia.
    American journal of clinical oncology, 1984, Volume: 7, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Bone Marro

1984